Delivery Order SPE2DB25D7056-SPE2DB25FTMUX
Award Date 7/17/25
Potential Completion Date 7/18/25
Potential Value $1.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 0.2% Ropivacaine, a local anesthetic medication, with a ceiling value of $1,431.54 and a completion date of July 9, 2025. The contract is not set aside and utilizes firm fixed price pricing. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 400 mg/200 mL of Ropivacaine 0.2% medication, with a ceiling value of $1,346.51 and a completion date of June 5, 2025. The contract is a firm fixed price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 200 mg/100 mL of the drug Ropivacaine 0.2%, with a ceiling value of $1,276.43. The contract is a firm fixed-price, non-set-aside award with a completion date of June 9, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 0.5% ropivacaine 150 mg/30 ml (30 ml) at a ceiling value of $2,104.56. The delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 0.2% Ropivacaine 400 mg/200 ml, a medication used for pain management. The contract has a ceiling value of $1,513.18 and a completion date of June 4, 2024. It is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the supply of 4557143835 - Ropivacaine 0.2% 400 mg/200 ml at a ceiling value of $1,297.38. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 400 mg/200 ml ropivacaine 0.2% solution. The contract is a firm fixed-price delivery order with a ceiling value of $4,004.37 and an ultimate completion date of February 4, 2025. The contract is not designated under any set-aside program. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 400 mg/200 ml vials of the anesthetic medication Ropivacaine 0.2%, with a ceiling value of $1,816.72 and a completion date of February 14, 2024. The contract is a firm fixed-price Indefinite Delivery Contract vehicle, with no set-aside designation, that allows the DLA to procure a...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 400 mg/200 mL ropivacaine 0.2% solution. The contract has a ceiling value of $15,136.95 and a period of performance through July 7, 2025. It is a firm-fixed-price delivery order contract, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,896.03 firm fixed-price contract is for the delivery of 4567829319 - Ropivacaine 0.2% 400 mg/200 ml 200 ml, with a period of performance through April 8, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical,...